Characteristics n (%) | Total n = 62 | R ≥ 3.5 n = 31 | R < 3.5 n = 31 | p-value |
---|---|---|---|---|
BAL’s data | ||||
Total cell count (× 103/ml) [median (IQR)] | 160 (100–250) | 145 (97–235) | 160 (100–275) | 0.471 |
Cell population % mean (SD) | ||||
Lymphocytes | 24.5 (15.9) | 28.4 (15.7) | 20.8 (15.5) | 0.071 |
Macrophages | 69 (5.2) | 66.3 (14.8) | 71.7 (15.3) | 0.184 |
Eosinophils | 0.6 (1.8) | 0.7 (1.8) | 0.6 (1.7) | 0.732 |
Neutrophils | 5.2 (7.1) | 4.7 (8.1) | 5.7 (6.0) | 0.599 |
CD4/CD8 ratio [median (IQR)] | 3.45 (1.88–7.26) | 6.84 (4.78–11.32) | 1.91 (1.28–2.81) | < 0.001 |
PFTs data | n = 59 | n = 31 | n = 28 | |
FEV-1 (L) [median (IQR)] | 2.94 (2.34–3.56) | 3.07 (2.57–3.74) | 2.75 (1.84–3.42) | 0.069 |
FVC (L) [median (IQR)] | 3.8 (2.92–4.48) | 3.89 (3.24–5.01) | 3.53 (2.47–4.15) | 0.092 |
DLCO (%) [median (IQR)] | 76 (66–87) | 81 (70–86) | 68 (60–88) | 0.057 |
CT-scan review [median (IQR)]** | n = 29 | n = 13 | n = 16 | |
Micronodular involvement [n (%)] | ||||
Sparce | 13 (44.8) | 5 (38.5) | 8 (50.0) | 0.534 |
Profuse | 7 (24.1) | 3 (23.1) | 4 (25.0) | 1.000§ |
Consolidation/conglomeration | 9 (31.0) | 5 (38.5) | 4 (25.0) | 0.688§ |
Traction bronchiectasis [n (%)] | 1 (3.4) | 0 (0) | 1 (6.3) | 1.000§ |